Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Type 1 Diabetes TrialNet Study Group

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals'. Together they form a unique fingerprint.

Medicine & Life Sciences